https://www.bizcommunity.com/80/398.html The Gambia Pharmaceuticals news 15 Pharmaceuticals news - The Gambia https://www.bizcommunity.com/res/img/logo.gif https://www.bizcommunity.com/80/398.html en-us Mon, 06 Apr 2026 11:39:42 +0200 https://www.bizcommunity.com/article/aspen-pharmacare-to-capitalise-on-glp-1-demand-in-sub-saharan-africa-844843a Aspen Pharmacare aims to secure sub‑Saharan African approval for Eli Lilly's blockbuster weight‑loss drug Mounjaro as early as this year, its CEO said, capitalising on soaring regional demand for obesity treatments. 1-266169 Wed, 04 Mar 2026 13:17:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/article/novartis-new-drug-more-than-97-effective-at-treating-malaria-407009a As it presented final-stage trial results, Novartis said the new antimalarial drug it is developing is as effective as existing treatments and could help tackle rising drug resistance. The drug, ganaplacide/lumefantrine or GanLum, was created by the company and the Medicines for Malaria Venture, a non-profit. 1-263265 Thu, 13 Nov 2025 13:02:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/article/biovac-boosts-africas-vaccine-capacity-with-new-lab-730062a With a little help from the Gates Foundation, Biovac will boost Africa’s vaccine manufacturing capacity with its newly opened product development laboratory in Cape Town. “For millions of people across the continent, it brings the promise of faster, more reliable access to lifesaving vaccines — developed and produced in Africa, for Africa,” said Gates Foundation CEO Mark Suzman. 1-263072 Thu, 06 Nov 2025 13:01:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/article/cholera-in-northwest-nigeria-limited-healthcare-access-leaves-communities-at-risk-735932a A cholera outbreak in the Bukkuyum district of Zamfara state, northwest Nigeria, has claimed at least eight lives and infected over 200 people across 11 communities, residents and local officials said, as limited healthcare access and insecurity exacerbate the crisis. 1-260862 Thu, 28 Aug 2025 10:00:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/Article/80/398/240179.html Families of 20 Gambian children who died after consuming cough syrups made in India will take their government to court this month for allegedly mishandling drug imports - a rare step in one of Africa's poorest countries, where few have the means to challenge authorities. 1-240179 Fri, 14 Jul 2023 11:48:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/Article/1/148/239496.html The board of directors of Abbott Laboratories (Pty) Ltd recently declared a quarterly common dividend of USD 51 cents per share. 1-239496 Thu, 22 Jun 2023 12:56:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/Article/1/162/230542.html Talc-based Johnson's Baby Powder will be discontinued globally in 2023, as Johnson & Johnson transitions its baby powder portfolio to cornstarch. 1-230542 Mon, 15 Aug 2022 09:30:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/Article/196/82/224382.html Brand Finance Global 500 2022, the most anticipated brand ranking of the year, have revealed the findings of the 16th annual study into the world's 500 most valuable and strongest brands across all sectors and countries. 1-224382 Wed, 26 Jan 2022 09:00:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/Article/1/784/224090.html GlaxoSmithKline (GSK), the owner of Aquafresh, Voltaren and Eno, has rejected a proposal from Unilever to acquire GSK's Consumer Healthcare business for a total acquisition value of £50bn, comprising £41.7bn in cash and £8.3bn in Unilever shares. 1-224090 Mon, 17 Jan 2022 08:46:00 +0200 Bizcommunity Pharmaceuticals The Gambia https://www.bizcommunity.com/Article/1/398/221860.html The drug policy median score across all 30 countries for humane and health driven drug policies is just 48/100, with Norway, despite topping the inaugural edition of the Global Drug Policy Index, still only managing a score of 74/100. The other four leading countries are New Zealand, Portugal, the UK and Australia, with Brazil, Uganda, Indonesia, Kenya, and Mexico the five lowest-ranking countries. 1-221860 Mon, 08 Nov 2021 06:44:00 +0200 Bizcommunity Pharmaceuticals The Gambia